Inventiva (IVA) Revenue (2020 - 2022)
Inventiva (IVA) recorded quarterly Revenue of $3.9 million in Q4 2022, up 4847.59% quarter-over-quarter from $78277.6 in Q2 2021.
Inventiva (IVA) Revenue (2020 - 2022) Analysis & Trends
Inventiva's Revenue history runs 3 years deep, the most recent figure standing at $3.9 million for Q4 2022.
- In Q4 2022, Revenue changed N/A year-over-year to $3.9 million; the TTM figure through Dec 2022 stood at $4.1 million (changed N/A YoY), while the FY2025 annual figure was $5.2 million, down 46.91% from the prior year.
- Revenue was $3.9 million for Q4 2022 at Inventiva, up from $78277.6 in the prior quarter.
- In the past five years, Revenue ranged from a high of $3.9 million in Q4 2022 to a low of $78277.6 in Q2 2021.
- Historically, Revenue has averaged $843589.8 across 3 years, with a median of $89261.5 in 2021.
- Biggest YoY gain for Revenue was 3.96% in 2021; the steepest drop was 7.06% in 2021.
- A 3-year view of Revenue shows it stood at $81508.0 in 2020, then slipped by 3.96% to $78277.6 in 2021, then soared by 4847.59% to $3.9 million in 2022.
- The last three Revenue figures came in at $3.9 million (Q4 2022), $78277.6 (Q2 2021), and $89261.5 (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Inventiva | 8.78 Mn | -259.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 3.87 Mn |
| Jun 30, 2021 | 78,277.64 |
| Mar 31, 2021 | 89,261.47 |
| Jun 30, 2020 | 81,508.05 |
| Mar 31, 2020 | 96,042.70 |